DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Bliss GVS Pharma Limited — Outcome of Board Meeting

NSE 1 hr ago·28 Sept 2026, 3:25 pm

Bliss GVS Pharma

Bliss GVS Pharma has informed the stock exchange that its promoters have voluntarily reclassified their stake from the 'Promoter and Promoter Group' category to the 'Public' category. This change means the company is now considered a 'public company' rather than a closely held one, as the promoters no longer hold a majority of the voting shares.

This move is often viewed positively by the market as it signals greater transparency and reduced concentration of ownership. It can also make the stock more attractive to institutional investors who may have restrictions on investing in companies with high promoter concentration. For retail investors, it is a neutral-to-positive development that enhances the company's corporate governance profile.